TRADING UPDATES: Marlowe buys; Galliford snaps up nmcn's Water unit
TRADING UPDATES: Marlowe buys; Galliford snaps up nmcn's Water unit
Read moreTue, 05th Apr 2016 12:33
TRADING UPDATES: Marlowe buys; Galliford snaps up nmcn's Water unit
Read moreIN BRIEF: Sareum expects annual loss to widen, increases R&D
Read more(Sharecast News) - British drugmaker Sareum said on Thursday that it expects to post a widened full-year loss as a result of increased research-and-development expenditure and delays in compound supply.
Read moreTRADING UPDATES: Netcall wins new deal; Sareum raises GBP1 million
Read more(Sharecast News) - Specialist drug development company Sareum noted on Friday that Sierra Oncology, the licence holder for the novel Chk1 inhibitor 'SRA737', had discussed its newly-announced global in-licensing agreement with AstraZeneca for AZD5153 with investors, which is a novel BRD4 BET inhibitor, to expand its myelofibrosis pipeline.
Read moreTRADING UPDATES: Capita and Custodian REIT agree disposals
Read moreAIM WINNERS & LOSERS: Sareum in patent boost; Airea flags uncertainty
Read moreTRADING UPDATES: Sareum raises GBP1 million; Marlowe buys Core Stream
Read moreTRADING UPDATES: Gym Group bulks up with placing; 88 Energy debt free
Read more(Sharecast News) - Specialist drug development company Sareum announced "encouraging" top-line results from its UKRI grant-funded Covid-19 research project on Thursday.
Read moreTRADING UPDATES: Tremor Nasdaq IPO underway; MGC's CannEpil in Ireland
Read moreTRADING UPDATES: Breedon buys Micromix; Marlowe acquires Alarm
Read moreAIM WINNERS & LOSERS: Sound Energy falls on Morocco tax notification
Read moreTRADING UPDATES: Mothercare sales down; Revolution Bars seeks to raise
Read more(Sharecast News) - Pharmaceutical company Sareum said on Tuesday that Covid-19 has continued to impact the contract research organisations it was working to complete pre-clinical development of its SDC-1801 drug candidate for autoimmune disease.
Read more